Literature DB >> 27373144

Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.

Rajib Ghosh1, Sanchita Roy1, Johan Kamyab1, Francoise Danzter2, Sonia Franco1.   

Abstract

In mammalian cells, chromatin poly(ADP-ribos)ylation (PARylation) at sites of DNA Double-Strand Breaks (DSBs) is mediated by two highly related enzymes, PARP1 and PARP2. However, enzyme-specific genetic interactions with other DSB repair factors remain largely undefined. In this context, it was previously shown that mice lacking PARP1 and H2AX, a histone variant that promotes DSB repair throughout the cell cycle, or the core nonhomologous end-joining (NHEJ) factor Ku80 are not viable, while mice lacking PARP1 and the noncore NHEJ factor DNA-PKcs are severely growth retarded and markedly lymphoma-prone. Here, we have examined the requirement for PARP2 in these backgrounds. We find that, like PARP1, PARP2 is essential for viability in mice lacking H2AX. Moreover, treatment of H2AX-deficient primary fibroblasts or B lymphocytes with PARP inhibitors leads to activation of the G2/M checkpoint and accumulation of chromatid-type breaks in a lineage- and gene-dose dependent manner. In marked contrast to PARP1, loss of PARP2 does not result in additional phenotypes in growth, development or tumorigenesis in mice lacking either Ku80 or DNA-PKcs. Altogether these findings highlight specific nonoverlapping functions of PARP1 and PARP2 at H2AX-deficient chromatin during replicative phases of the cell cycle and uncover a unique requirement for PARP1 in NHEJ-deficient cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA-PKcs; Double-strand breaks; H2AX; Ku80; PARP1; PARP2

Mesh:

Substances:

Year:  2016        PMID: 27373144      PMCID: PMC4979568          DOI: 10.1016/j.dnarep.2016.06.001

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  61 in total

1.  PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.

Authors:  I Rybanska; O Ishaq; J Chou; M Prakash; J Bakhsheshian; D L Huso; S Franco
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

2.  PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase.

Authors:  J C Amé; V Rolli; V Schreiber; C Niedergang; F Apiou; P Decker; S Muller; T Höger; J Ménissier-de Murcia; G de Murcia
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

3.  Differential requirement for H2AX and 53BP1 in organismal development and genome maintenance in the absence of poly(ADP)ribosyl polymerase 1.

Authors:  Benjamin Orsburn; Beatriz Escudero; Mansi Prakash; Silvia Gesheva; Guosheng Liu; David L Huso; Sonia Franco
Journal:  Mol Cell Biol       Date:  2010-03-15       Impact factor: 4.272

4.  53BP1 is limiting for NHEJ repair in ATM-deficient model systems that are subjected to oncogenic stress or radiation.

Authors:  Ivana Rybanska-Spaeder; Taylor L Reynolds; Jeremy Chou; Mansi Prakash; Tameca Jefferson; David L Huso; Stephen Desiderio; Sonia Franco
Journal:  Mol Cancer Res       Date:  2013-07-15       Impact factor: 5.852

5.  The absence of the dna-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang.

Authors:  F A Goytisolo; E Samper; S Edmonson; G E Taccioli; M A Blasco
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

6.  H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.

Authors:  Arkady Celeste; Simone Difilippantonio; Michael J Difilippantonio; Oscar Fernandez-Capetillo; Duane R Pilch; Olga A Sedelnikova; Michael Eckhaus; Thomas Ried; William M Bonner; André Nussenzweig
Journal:  Cell       Date:  2003-08-08       Impact factor: 41.582

7.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

Authors:  Z Q Wang; B Auer; L Stingl; H Berghammer; D Haidacher; M Schweiger; E F Wagner
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

8.  PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites.

Authors:  Jean-François Haince; Darin McDonald; Amélie Rodrigue; Ugo Déry; Jean-Yves Masson; Michael J Hendzel; Guy G Poirier
Journal:  J Biol Chem       Date:  2007-11-19       Impact factor: 5.157

9.  DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair.

Authors:  Songmin Ying; Zhihui Chen; Annette L Medhurst; Jessica A Neal; Zhengqiang Bao; Oliver Mortusewicz; Joanna McGouran; Xinming Song; Huahao Shen; Freddie C Hamdy; Benedikt M Kessler; Katheryn Meek; Thomas Helleday
Journal:  Cancer Res       Date:  2015-11-24       Impact factor: 12.701

10.  Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

Authors:  Junko Murai; Shar-yin N Huang; Benu Brata Das; Amelie Renaud; Yiping Zhang; James H Doroshow; Jiuping Ji; Shunichi Takeda; Yves Pommier
Journal:  Cancer Res       Date:  2012-11-01       Impact factor: 13.312

View more
  9 in total

Review 1.  The recent advances in non-homologous end-joining through the lens of lymphocyte development.

Authors:  Xiaobin S Wang; Brian J Lee; Shan Zha
Journal:  DNA Repair (Amst)       Date:  2020-06-25

Review 2.  Understanding specific functions of PARP-2: new lessons for cancer therapy.

Authors:  Syed O Ali; Farhaan A Khan; Miguel A Galindo-Campos; José Yélamos
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

3.  The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1.

Authors:  Oleg Kruglov; Xuesong Wu; Sam T Hwang; Oleg E Akilov
Journal:  Blood Adv       Date:  2020-10-13

4.  Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation.

Authors:  Gabriella Zarkovic; Ekaterina A Belousova; Ibtissam Talhaoui; Christine Saint-Pierre; Mikhail M Kutuzov; Bakhyt T Matkarimov; Denis Biard; Didier Gasparutto; Olga I Lavrik; Alexander A Ishchenko
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

5.  Identification of Differentially Expressed Genes between Original Breast Cancer and Xenograft Using Machine Learning Algorithms.

Authors:  Deling Wang; Jia-Rui Li; Yu-Hang Zhang; Lei Chen; Tao Huang; Yu-Dong Cai
Journal:  Genes (Basel)       Date:  2018-03-12       Impact factor: 4.096

6.  The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma.

Authors:  Hye Jeong Park; Jun Sang Bae; Kyoung Min Kim; Young Jae Moon; See-Hyoung Park; Sang Hoon Ha; Usama Khamis Hussein; Zhongkai Zhang; Ho Sung Park; Byung-Hyun Park; Woo Sung Moon; Jung Ryul Kim; Kyu Yun Jang
Journal:  J Exp Clin Cancer Res       Date:  2018-05-21

7.  Structural basis for DNA break recognition by ARTD2/PARP2.

Authors:  Ezeogo Obaji; Teemu Haikarainen; Lari Lehtiö
Journal:  Nucleic Acids Res       Date:  2018-12-14       Impact factor: 16.971

8.  Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.

Authors:  Paulina Gil-Kulik; Ewa Dudzińska; Elżbieta Radzikowska-Büchner; Joanna Wawer; Mariusz Jojczuk; Adam Nogalski; Genowefa Anna Wawer; Marcin Feldo; Wojciech Kocki; Maria Cioch; Anna Bogucka-Kocka; Mansur Rahnama; Janusz Kocki
Journal:  BMC Cancer       Date:  2020-05-18       Impact factor: 4.430

Review 9.  Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer.

Authors:  Huanhuan Sha; Yujie Gan; Renrui Zou; Jianzhong Wu; Jifeng Feng
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.